| Closed |
S0124 |
Cis/Irinotecan vs. Cis/VP-16 in Extensive SCLC |
11/1/2002 |
3/1/2007 |
99% |
|
Published
|
| Closed |
S0023 |
Cis/VP-16/RT/Consol. Doc followed by ZD1839/Placebo /IIIA & selected IIIB NSCLC |
6/15/2001 |
4/15/2005 |
74% |
|
Published
|
| Closed |
S0220 |
Cis/VP-16/RT/Surgery/Doc/Selected IIB, Stage IIIA or IIIB (Pancoast Tumors) |
7/1/2003 |
10/1/2007 |
92% |
|
Published
|
| Closed |
S0122 |
Cisplat/Etopo/RT followed by Cisplat/Etopo/TriAb & TriGem Vaccines in Limited SCLC |
12/15/2002 |
5/15/2003 |
10% |
|
|
| Closed |
SWOG-8850 |
Cisplatin and Novobiocin in the Treatment of Stage IV, Stage IIIb or Locally Recurrent Tumor After Radiation Therapy of Non-Small Cell Lung Cancer (NSCLC) |
8/15/1988 |
6/1/1990 |
72% |
|
Published
|
| Closed |
S0533 |
Cisplatin/Etoposide/RT/Docetaxel and Three Cohorts of Bevacizumab-Advanced Stage III NSCLC |
6/15/2006 |
3/1/2010 |
16% |
|
Published
|
| Closed |
SWOG-8901 |
Clinical Trial of the Most Active Drugs Selected by Clonogenic Assay to be Administered by the Intrahepatic Arterial Route for Colorectal Cancer Metastatic to the Liver |
9/1/1990 |
10/15/1991 |
5% |
|
|
| Closed |
SWOG-8897 |
CMF vs. CAF ± Tamoxifen in High-Risk, Node Neg. |
7/15/1989 |
2/1/1993 |
100% |
|
Published
|
| Closed |
SWOG-7725 |
CMFP vs. CMFP + Levamisole for ER-Patients with Breast Cancer |
10/10/1977 |
7/24/1980 |
|
|
|
| Closed |
SWOG-7436 |
CMFVP vs Melphalan for operable breast cancer |
1/9/1975 |
7/18/1979 |
100% |
|
Published
|
| Closed |
SWOG-8014 |
Colchicine in Refractory Chronic Lymphocytic Leukemia |
7/7/1980 |
10/23/1981 |
|
|
|
| Closed |
SWOG-7960 |
Colchicine in Refractory Hodgkin's Disease, CLL, Lung and Breast Cancer |
2/28/1979 |
7/7/1980 |
|
|
|
| Closed |
SWOG-9419 |
COLORECTAL |
3/15/1995 |
8/15/2001 |
|
|
|
| Closed |
S9635 |
COLORECTAL |
4/1/1998 |
9/15/2000 |
49% |
|
Published
|
| Closed |
S9923 |
COLORECTAL |
6/1/2000 |
8/1/2001 |
100% |
|
Published
|
| Closed |
S0030 |
COLORECTAL |
2/1/2003 |
2/1/2005 |
48% |
|
Published
|
| Closed |
S0303 |
COLORECTAL |
4/1/2004 |
9/1/2004 |
2% |
|
|
| Closed |
S0336 |
COLORECTAL |
4/15/2004 |
9/1/2005 |
70% |
|
Published
|
| Closed |
S0408 |
COLORECTAL |
11/15/2006 |
4/1/2007 |
0% |
|
|
| Closed |
S0600 |
Colorectal Ph III irinotecan-based chemo + cetuximab or bevacizumab |
6/15/2007 |
11/10/2010 |
11% |
|
Published
|
